Associations between long-term exposure to PM2.5 and site-specific cancer mortality: A nationwide study in Brazil between 2010 and 2018

Imagem de Miniatura
Arquivos
art_YU_Associations_between_longterm_exposure_to_PM25_and_sitespecific_2022.PDF (4.2 MB)
Citações na Scopus
26
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
YU, Pei
XU, Rongbin
LI, Shanshan
SIM, Malcolm R.
ABRAMSON, Michael J.
GUO, Yuming
Citação
ENVIRONMENTAL POLLUTION, v.302, article ID 119070, 8p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Long-term exposure to PM2.5 has been linked to lung cancer incidence and mortality, but limited evidence existed for other cancers. This study aimed to assess the association between PM2.5 on cancer specific mortality. An ecological study based on the cancer mortality data collected from 5,565 Brazilian cities during 2010-2018 using a difference-in-differences approach with quasi-Poisson regression, was applied to examine PM2.5-cancer mortality associations. Globally gridded annual average surface PM2.5 concentration was extracted and linked with the residential municipality of participants in this study. Sex, age stratified and exposure-response estimations were also conducted. Totalling 1,768,668 adult cancer deaths records of about 208 million population living across 5,565 municipalities were included in this study. The average PM2.5 concentration was 7.63 mu g/m(3) (standard deviation 3.32) with range from 2.95 mu g/m(3) to 28.5 mu g/m(3). With each 10 mu g/m(3) increase in three-year average (current year and previous two years) concentrations of PM2.5, the relative risks (RR) of cancer mortality were 1.16 (95% confidence interval [CI]: 1.11-1.20) for all-site cancers. The PM2.5 exposure was significantly associated with several cancer-specific mortalities including oral, nasopharynx, oesophagus, and stomach, colon rectum, liver, gallbladder, larynx, lung, bone, skin, female breast, cervix, prostate, brain and leukaemia. No safe level of PM2.5 exposure was observed in the exposure-response curve for all types of cancer. In conclusion, with nationwide cancer death records in Brazil, we found that long-term exposure to ambient PM2.5 increased risks of mortality for many cancer types. Even low level PM2.5 concentrations had significant impacts on cancer mortality.
Palavras-chave
Cancer, Particulate matter, Mortality, Difference in differences
URI
https://observatorio.fm.usp.br/handle/OPI/47250
Referências
  1. Silva GAE, 2020, REV SAUDE PUBL, V54, DOI [10.1160/s1518-8787.2020054002255, 10.11606/s1518-8787.2020054002255]
  2. Bowe B, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15834
  3. Bray F, 2021, CANCER-AM CANCER SOC, V127, P3029, DOI 10.1002/cncr.33587
  4. Chang FW, 2019, TAIWAN J OBSTET GYNE, V58, P282, DOI 10.1016/j.tjog.2019.01.021
  5. Coleman NC, 2021, JNCI CANCER SPECT, V5, DOI 10.1093/jncics/pkab001
  6. Coleman NC, 2020, CANCER CAUSE CONTROL, V31, P767, DOI 10.1007/s10552-020-01317-w
  7. Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
  8. Deng HY, 2017, INT J CANCER, V141, P744, DOI 10.1002/ijc.30779
  9. Eckel SP, 2016, THORAX, V71, P891, DOI 10.1136/thoraxjnl-2015-207927
  10. Gill JG, 2016, COLD SH Q B, V81, P163, DOI 10.1101/sqb.2016.81.030791
  11. Glencross DA, 2020, FREE RADICAL BIO MED, V151, P56, DOI 10.1016/j.freeradbiomed.2020.01.179
  12. Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6
  13. Guo C, 2020, ENVIRON INT, V138, DOI 10.1016/j.envint.2020.105640
  14. Guo YM, 2017, SCI TOTAL ENVIRON, V579, P1460, DOI 10.1016/j.scitotenv.2016.11.147
  15. Hammer MS, 2020, ENVIRON SCI TECHNOL, V54, P7879, DOI 10.1021/acs.est.0c01764
  16. Hu H, 2013, BREAST CANCER RES TR, V139, P217, DOI 10.1007/s10549-013-2527-9
  17. Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289
  18. Joint FAO/WHO Expert Committee on Food Additives, 2006, World Health Organ Tech Rep Ser, V930, P1
  19. Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003
  20. Katanoda K, 2011, J EPIDEMIOL, V21, P132, DOI 10.2188/jea.JE20100098
  21. Klaunig JE, 2018, CURR PHARM DESIGN, V24, P4771, DOI 10.2174/1381612825666190215121712
  22. Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0
  23. Lehrer Steven, 2014, Clin Thyroidol, V26, P273
  24. Li R, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00343-5
  25. Luo F, 2021, CHEMOSPHERE, V263, DOI 10.1016/j.chemosphere.2020.127867
  26. Ma QY, 2017, INT IMMUNOPHARMACOL, V50, P139, DOI 10.1016/j.intimp.2017.06.019
  27. Morais Rinaldo Macedo de, 2017, Saúde debate, V41, P101, DOI 10.1590/0103-11042017s09
  28. Pinault LL, 2017, ENVIRON RES, V159, P406, DOI 10.1016/j.envres.2017.08.037
  29. Pineros, 2020, GLOBAL CANC OBSERVAT
  30. Pope CA, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4438
  31. Pun VC, 2017, AM J EPIDEMIOL, V186, P961, DOI 10.1093/aje/kwx166
  32. Renzi M, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP3759
  33. Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006
  34. Rolston KVI, 2017, INFECT DIS THER, V6, P69, DOI 10.1007/s40121-017-0146-1
  35. Roos WP, 2016, NAT REV CANCER, V16, P20, DOI 10.1038/nrc.2015.2
  36. Schwartz J, 2021, ENVIRON RES, V194, DOI 10.1016/j.envres.2020.110649
  37. Sharma A., 2017, TUMOUR BIOL, V39, DOI [10.1177/ 1010428317724784, DOI 10.1177/1010428317724784]
  38. Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551
  39. Stiller C, 2002, MED PEDIATR ONCOL, V39, P149, DOI 10.1002/mpo.10142
  40. Strongman H, 2019, LANCET, V394, P1041, DOI 10.1016/S0140-6736(19)31674-5
  41. Turner MC, 2020, CA-CANCER J CLIN, V70, P460, DOI 10.3322/caac.21632
  42. Wang H, 2019, CHEMOSPHERE, V216, P766, DOI 10.1016/j.chemosphere.2018.10.183
  43. Wild CP, 2019, NAT REV CANCER, V19, P123, DOI 10.1038/s41568-019-0110-3
  44. Wong CM, 2016, CANCER EPIDEM BIOMAR, V25, P839, DOI 10.1158/1055-9965.EPI-15-0626
  45. Xu RB, 2020, LANCET PLANET HEALTH, V4, pE566, DOI 10.1016/S2542-5196(20)30251-5
  46. Xu RB, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003369
  47. Yu P, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100143
  48. Yu P, 2021, ENVIRON INT, V154, DOI 10.1016/j.envint.2021.106671
  49. Yu WH, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003141
  50. Zhao Q, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.04.013
  51. Zhao Q, 2019, ENVIRON HEALTH PERSP, V127, DOI [10.1289/EHP3889, 10.1289/ehp3889]

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/05
Artigos e Materiais de Revistas Científicas - ODS/03